Otsuka Pharmaceutical Co., Ltd, Saga Plant - B001203
Tesis Brezilya sağlık düzenleme kurumu (ANVISA) tarafından onaylanmıştır
Brezilya sağlık düzenleme kurumu ANVISA, bu tesis için aktif farmasötik içerikleri kapsayan ve 30.10.2027 tarihine kadar geçerli olan geçerli bir İyi Üretim Uygulaması sertifikasına sahiptir. Sertifika, tesisin kendi incelemesinden sonra veriliyor, bu nedenle yabancı bir düzenleyici bu siteyi adlandırıyor: Burada üretilen malların Brezilya pazarında bulunmasına izin veriliyor. İşlem numarası 25351568266202309.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Japan
- Categories
- İlaç Üretimi
- Markets
- Japonya, Brezilya
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- debarment-clear (green), checked 2026-09-02 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- sanctions-clear (green), checked 2026-09-02 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)